nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Alzheimer's disease	0.497	1	CbGaD
Clodronate—SLC25A6—embryo—Alzheimer's disease	0.0106	0.0822	CbGeAlD
Clodronate—SLC25A6—forebrain—Alzheimer's disease	0.0094	0.0727	CbGeAlD
Clodronate—SLC25A5—embryo—Alzheimer's disease	0.00925	0.0715	CbGeAlD
Clodronate—SLC25A6—telencephalon—Alzheimer's disease	0.00865	0.0669	CbGeAlD
Clodronate—SLC25A5—forebrain—Alzheimer's disease	0.00818	0.0633	CbGeAlD
Clodronate—SLC25A4—forebrain—Alzheimer's disease	0.00767	0.0593	CbGeAlD
Clodronate—SLC25A5—telencephalon—Alzheimer's disease	0.00752	0.0582	CbGeAlD
Clodronate—SLC25A4—telencephalon—Alzheimer's disease	0.00705	0.0545	CbGeAlD
Clodronate—Stomach ache—Rivastigmine—Alzheimer's disease	0.0058	0.0374	CcSEcCtD
Clodronate—SLC25A6—nervous system—Alzheimer's disease	0.0051	0.0395	CbGeAlD
Clodronate—SLC25A6—central nervous system—Alzheimer's disease	0.00491	0.038	CbGeAlD
Clodronate—SLC25A6—cerebellum—Alzheimer's disease	0.0048	0.0371	CbGeAlD
Clodronate—SLC25A5—nervous system—Alzheimer's disease	0.00444	0.0343	CbGeAlD
Clodronate—SLC25A5—central nervous system—Alzheimer's disease	0.00428	0.0331	CbGeAlD
Clodronate—SLC25A5—cerebellum—Alzheimer's disease	0.00418	0.0323	CbGeAlD
Clodronate—SLC25A4—nervous system—Alzheimer's disease	0.00416	0.0322	CbGeAlD
Clodronate—SLC25A4—central nervous system—Alzheimer's disease	0.00401	0.031	CbGeAlD
Clodronate—SLC25A4—cerebellum—Alzheimer's disease	0.00392	0.0303	CbGeAlD
Clodronate—SLC25A6—brain—Alzheimer's disease	0.0039	0.0302	CbGeAlD
Clodronate—SLC25A5—brain—Alzheimer's disease	0.00339	0.0263	CbGeAlD
Clodronate—SLC25A4—brain—Alzheimer's disease	0.00318	0.0246	CbGeAlD
Clodronate—PTGS2—blood vessel—Alzheimer's disease	0.00292	0.0226	CbGeAlD
Clodronate—Creatinine increased—Donepezil—Alzheimer's disease	0.00292	0.0188	CcSEcCtD
Clodronate—Neoplasm malignant—Rivastigmine—Alzheimer's disease	0.00289	0.0186	CcSEcCtD
Clodronate—Renal impairment—Galantamine—Alzheimer's disease	0.00273	0.0176	CcSEcCtD
Clodronate—Wheezing—Donepezil—Alzheimer's disease	0.0027	0.0174	CcSEcCtD
Clodronate—Oliguria—Rivastigmine—Alzheimer's disease	0.00268	0.0172	CcSEcCtD
Clodronate—Cardiac failure—Galantamine—Alzheimer's disease	0.00267	0.0172	CcSEcCtD
Clodronate—Creatinine increased—Memantine—Alzheimer's disease	0.00265	0.0171	CcSEcCtD
Clodronate—Dehydration—Galantamine—Alzheimer's disease	0.00242	0.0156	CcSEcCtD
Clodronate—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00238	0.0153	CcSEcCtD
Clodronate—Dysphagia—Galantamine—Alzheimer's disease	0.00225	0.0145	CcSEcCtD
Clodronate—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00209	0.0135	CcSEcCtD
Clodronate—Cardiac failure—Donepezil—Alzheimer's disease	0.00207	0.0133	CcSEcCtD
Clodronate—Pneumonia—Galantamine—Alzheimer's disease	0.00202	0.013	CcSEcCtD
Clodronate—Renal failure acute—Memantine—Alzheimer's disease	0.00198	0.0128	CcSEcCtD
Clodronate—Renal failure—Galantamine—Alzheimer's disease	0.00197	0.0127	CcSEcCtD
Clodronate—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00194	0.0125	CcSEcCtD
Clodronate—Renal impairment—Memantine—Alzheimer's disease	0.00192	0.0124	CcSEcCtD
Clodronate—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00189	0.0122	CcSEcCtD
Clodronate—Renal impairment—Rivastigmine—Alzheimer's disease	0.00188	0.0121	CcSEcCtD
Clodronate—Cardiac failure—Memantine—Alzheimer's disease	0.00188	0.0121	CcSEcCtD
Clodronate—Dehydration—Donepezil—Alzheimer's disease	0.00188	0.0121	CcSEcCtD
Clodronate—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00184	0.0119	CcSEcCtD
Clodronate—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00184	0.0118	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00178	0.0115	CcSEcCtD
Clodronate—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00178	0.0115	CcSEcCtD
Clodronate—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00177	0.0114	CcSEcCtD
Clodronate—Urethral disorder—Galantamine—Alzheimer's disease	0.00176	0.0114	CcSEcCtD
Clodronate—Dysphagia—Donepezil—Alzheimer's disease	0.00174	0.0112	CcSEcCtD
Clodronate—PTGS2—embryo—Alzheimer's disease	0.00174	0.0135	CbGeAlD
Clodronate—Blood creatinine increased—Memantine—Alzheimer's disease	0.00172	0.011	CcSEcCtD
Clodronate—Dehydration—Memantine—Alzheimer's disease	0.0017	0.011	CcSEcCtD
Clodronate—Dehydration—Rivastigmine—Alzheimer's disease	0.00167	0.0107	CcSEcCtD
Clodronate—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00164	0.0105	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00161	0.0104	CcSEcCtD
Clodronate—Dysphagia—Memantine—Alzheimer's disease	0.00158	0.0102	CcSEcCtD
Clodronate—Pneumonia—Donepezil—Alzheimer's disease	0.00156	0.0101	CcSEcCtD
Clodronate—Bronchospasm—Memantine—Alzheimer's disease	0.00156	0.01	CcSEcCtD
Clodronate—Dysphagia—Rivastigmine—Alzheimer's disease	0.00155	0.00997	CcSEcCtD
Clodronate—PTGS2—forebrain—Alzheimer's disease	0.00154	0.0119	CbGeAlD
Clodronate—Renal failure—Donepezil—Alzheimer's disease	0.00153	0.00984	CcSEcCtD
Clodronate—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00152	0.00981	CcSEcCtD
Clodronate—Anaemia—Galantamine—Alzheimer's disease	0.00145	0.00933	CcSEcCtD
Clodronate—Pneumonia—Memantine—Alzheimer's disease	0.00142	0.00914	CcSEcCtD
Clodronate—PTGS2—telencephalon—Alzheimer's disease	0.00142	0.011	CbGeAlD
Clodronate—Pneumonia—Rivastigmine—Alzheimer's disease	0.00139	0.00894	CcSEcCtD
Clodronate—Renal failure—Memantine—Alzheimer's disease	0.00139	0.00893	CcSEcCtD
Clodronate—Pharyngitis—Donepezil—Alzheimer's disease	0.00138	0.00892	CcSEcCtD
Clodronate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00138	0.00887	CcSEcCtD
Clodronate—Urethral disorder—Donepezil—Alzheimer's disease	0.00137	0.00881	CcSEcCtD
Clodronate—Renal failure—Rivastigmine—Alzheimer's disease	0.00136	0.00874	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00132	0.00853	CcSEcCtD
Clodronate—Pharyngitis—Memantine—Alzheimer's disease	0.00126	0.0081	CcSEcCtD
Clodronate—Urinary tract disorder—Memantine—Alzheimer's disease	0.00125	0.00806	CcSEcCtD
Clodronate—Connective tissue disorder—Memantine—Alzheimer's disease	0.00124	0.00802	CcSEcCtD
Clodronate—Skin disorder—Galantamine—Alzheimer's disease	0.00124	0.008	CcSEcCtD
Clodronate—Urethral disorder—Memantine—Alzheimer's disease	0.00124	0.008	CcSEcCtD
Clodronate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00123	0.00792	CcSEcCtD
Clodronate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00788	CcSEcCtD
Clodronate—Anorexia—Galantamine—Alzheimer's disease	0.00122	0.00785	CcSEcCtD
Clodronate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00784	CcSEcCtD
Clodronate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00121	0.00782	CcSEcCtD
Clodronate—Mediastinal disorder—Memantine—Alzheimer's disease	0.00114	0.00735	CcSEcCtD
Clodronate—Dyspepsia—Galantamine—Alzheimer's disease	0.00113	0.00725	CcSEcCtD
Clodronate—Anaemia—Donepezil—Alzheimer's disease	0.00112	0.00723	CcSEcCtD
Clodronate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00112	0.00719	CcSEcCtD
Clodronate—Decreased appetite—Galantamine—Alzheimer's disease	0.00111	0.00716	CcSEcCtD
Clodronate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0011	0.00711	CcSEcCtD
Clodronate—Anaemia—Memantine—Alzheimer's disease	0.00102	0.00656	CcSEcCtD
Clodronate—Abdominal pain—Galantamine—Alzheimer's disease	0.00101	0.00651	CcSEcCtD
Clodronate—Anaemia—Rivastigmine—Alzheimer's disease	0.000997	0.00642	CcSEcCtD
Clodronate—Infection—Donepezil—Alzheimer's disease	0.000985	0.00634	CcSEcCtD
Clodronate—Anorexia—Donepezil—Alzheimer's disease	0.000945	0.00609	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000912	0.00587	CcSEcCtD
Clodronate—Infection—Memantine—Alzheimer's disease	0.000894	0.00576	CcSEcCtD
Clodronate—Dyspnoea—Donepezil—Alzheimer's disease	0.000884	0.00569	CcSEcCtD
Clodronate—Diarrhoea—Galantamine—Alzheimer's disease	0.000875	0.00564	CcSEcCtD
Clodronate—Infection—Rivastigmine—Alzheimer's disease	0.000874	0.00563	CcSEcCtD
Clodronate—Skin disorder—Memantine—Alzheimer's disease	0.000874	0.00563	CcSEcCtD
Clodronate—Dyspepsia—Donepezil—Alzheimer's disease	0.000872	0.00562	CcSEcCtD
Clodronate—Decreased appetite—Donepezil—Alzheimer's disease	0.000861	0.00555	CcSEcCtD
Clodronate—Anorexia—Memantine—Alzheimer's disease	0.000858	0.00553	CcSEcCtD
Clodronate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000856	0.00551	CcSEcCtD
Clodronate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000855	0.00551	CcSEcCtD
Clodronate—Anorexia—Rivastigmine—Alzheimer's disease	0.000839	0.00541	CcSEcCtD
Clodronate—PTGS2—nervous system—Alzheimer's disease	0.000836	0.00647	CbGeAlD
Clodronate—Vomiting—Galantamine—Alzheimer's disease	0.000813	0.00524	CcSEcCtD
Clodronate—Rash—Galantamine—Alzheimer's disease	0.000806	0.00519	CcSEcCtD
Clodronate—Dermatitis—Galantamine—Alzheimer's disease	0.000806	0.00519	CcSEcCtD
Clodronate—PTGS2—central nervous system—Alzheimer's disease	0.000805	0.00623	CbGeAlD
Clodronate—Dyspnoea—Memantine—Alzheimer's disease	0.000802	0.00517	CcSEcCtD
Clodronate—Dyspepsia—Memantine—Alzheimer's disease	0.000792	0.0051	CcSEcCtD
Clodronate—Urticaria—Donepezil—Alzheimer's disease	0.000787	0.00507	CcSEcCtD
Clodronate—PTGS2—cerebellum—Alzheimer's disease	0.000787	0.00609	CbGeAlD
Clodronate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000785	0.00506	CcSEcCtD
Clodronate—Abdominal pain—Donepezil—Alzheimer's disease	0.000783	0.00505	CcSEcCtD
Clodronate—Decreased appetite—Memantine—Alzheimer's disease	0.000782	0.00504	CcSEcCtD
Clodronate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000777	0.005	CcSEcCtD
Clodronate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000775	0.00499	CcSEcCtD
Clodronate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000765	0.00493	CcSEcCtD
Clodronate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00076	0.0049	CcSEcCtD
Clodronate—Nausea—Galantamine—Alzheimer's disease	0.00076	0.00489	CcSEcCtD
Clodronate—Urticaria—Memantine—Alzheimer's disease	0.000715	0.00461	CcSEcCtD
Clodronate—Abdominal pain—Memantine—Alzheimer's disease	0.000711	0.00458	CcSEcCtD
Clodronate—Pruritus—Donepezil—Alzheimer's disease	0.000701	0.00452	CcSEcCtD
Clodronate—Urticaria—Rivastigmine—Alzheimer's disease	0.000699	0.0045	CcSEcCtD
Clodronate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000696	0.00448	CcSEcCtD
Clodronate—Diarrhoea—Donepezil—Alzheimer's disease	0.000678	0.00437	CcSEcCtD
Clodronate—PTGS2—brain—Alzheimer's disease	0.000639	0.00494	CbGeAlD
Clodronate—Pruritus—Memantine—Alzheimer's disease	0.000637	0.0041	CcSEcCtD
Clodronate—Vomiting—Donepezil—Alzheimer's disease	0.00063	0.00406	CcSEcCtD
Clodronate—Rash—Donepezil—Alzheimer's disease	0.000625	0.00403	CcSEcCtD
Clodronate—Dermatitis—Donepezil—Alzheimer's disease	0.000624	0.00402	CcSEcCtD
Clodronate—Pruritus—Rivastigmine—Alzheimer's disease	0.000623	0.00401	CcSEcCtD
Clodronate—Diarrhoea—Memantine—Alzheimer's disease	0.000616	0.00397	CcSEcCtD
Clodronate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000602	0.00388	CcSEcCtD
Clodronate—Nausea—Donepezil—Alzheimer's disease	0.000589	0.00379	CcSEcCtD
Clodronate—Vomiting—Memantine—Alzheimer's disease	0.000572	0.00369	CcSEcCtD
Clodronate—Rash—Memantine—Alzheimer's disease	0.000567	0.00365	CcSEcCtD
Clodronate—Dermatitis—Memantine—Alzheimer's disease	0.000567	0.00365	CcSEcCtD
Clodronate—Vomiting—Rivastigmine—Alzheimer's disease	0.00056	0.00361	CcSEcCtD
Clodronate—Rash—Rivastigmine—Alzheimer's disease	0.000555	0.00358	CcSEcCtD
Clodronate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000554	0.00357	CcSEcCtD
Clodronate—Nausea—Memantine—Alzheimer's disease	0.000534	0.00344	CcSEcCtD
Clodronate—Nausea—Rivastigmine—Alzheimer's disease	0.000523	0.00337	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000177	0.000811	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MAOB—Alzheimer's disease	0.000177	0.00081	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—F2—Alzheimer's disease	0.000176	0.000805	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ABCA1—Alzheimer's disease	0.000174	0.000798	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IAPP—Alzheimer's disease	0.000174	0.000797	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS1—Alzheimer's disease	0.000172	0.000787	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ENO1—Alzheimer's disease	0.000172	0.000787	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NGFR—Alzheimer's disease	0.000171	0.000785	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000171	0.000782	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GAPDH—Alzheimer's disease	0.00017	0.00078	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CYP2D6—Alzheimer's disease	0.000168	0.000771	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000165	0.000758	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—A2M—Alzheimer's disease	0.000164	0.000753	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ADAM10—Alzheimer's disease	0.000164	0.000751	CbGpPWpGaD
Clodronate—SLC25A5—Disease—LPL—Alzheimer's disease	0.000163	0.000748	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Alzheimer's disease	0.000161	0.000736	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ENO1—Alzheimer's disease	0.00016	0.000733	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—BCHE—Alzheimer's disease	0.00016	0.000731	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PPP3CA—Alzheimer's disease	0.000159	0.00073	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—INS—Alzheimer's disease	0.000159	0.000729	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000159	0.000729	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PRKCG—Alzheimer's disease	0.000159	0.000727	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CCL2—Alzheimer's disease	0.000157	0.000717	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000155	0.000709	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—IGF1—Alzheimer's disease	0.000154	0.000705	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GAB2—Alzheimer's disease	0.000153	0.0007	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000152	0.000697	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GSK3A—Alzheimer's disease	0.000151	0.000693	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PLCB1—Alzheimer's disease	0.000151	0.00069	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CCR5—Alzheimer's disease	0.00015	0.000689	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPARGC1A—Alzheimer's disease	0.00015	0.000688	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HMOX1—Alzheimer's disease	0.000149	0.000685	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—Alzheimer's disease	0.000149	0.000683	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APP—Alzheimer's disease	0.000149	0.000682	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Alzheimer's disease	0.000148	0.000679	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MTHFR—Alzheimer's disease	0.000147	0.000673	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCA1—Alzheimer's disease	0.000146	0.000669	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—LEP—Alzheimer's disease	0.000145	0.000666	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1A—Alzheimer's disease	0.000143	0.000656	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ACHE—Alzheimer's disease	0.000143	0.000655	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000143	0.000653	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INPP5D—Alzheimer's disease	0.000141	0.000648	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—F2—Alzheimer's disease	0.00014	0.00064	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CALM1—Alzheimer's disease	0.000137	0.000629	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—F2—Alzheimer's disease	0.000137	0.000628	CbGpPWpGaD
Clodronate—SLC25A5—Disease—APOE—Alzheimer's disease	0.000137	0.000627	CbGpPWpGaD
Clodronate—SLC25A6—Disease—LPL—Alzheimer's disease	0.000137	0.000627	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—LPL—Alzheimer's disease	0.000137	0.000626	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CAV1—Alzheimer's disease	0.000136	0.000621	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000135	0.000617	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000134	0.000616	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS1—Alzheimer's disease	0.000134	0.000614	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ENO1—Alzheimer's disease	0.000134	0.000614	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PRKCG—Alzheimer's disease	0.000133	0.000609	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000132	0.000607	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000132	0.000603	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CYP2D6—Alzheimer's disease	0.000131	0.000602	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ADAM10—Alzheimer's disease	0.000128	0.000586	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—Alzheimer's disease	0.000127	0.000584	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000127	0.00058	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000126	0.000579	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOTCH1—Alzheimer's disease	0.000126	0.000579	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CCR5—Alzheimer's disease	0.000126	0.000577	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARGC1A—Alzheimer's disease	0.000126	0.000576	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—HMOX1—Alzheimer's disease	0.000125	0.000574	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—BCHE—Alzheimer's disease	0.000125	0.000571	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000124	0.00057	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—INS—Alzheimer's disease	0.000124	0.000569	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MTHFR—Alzheimer's disease	0.000123	0.000564	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—MTHFR—Alzheimer's disease	0.000123	0.000564	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CCL2—Alzheimer's disease	0.000122	0.00056	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—IGF1—Alzheimer's disease	0.00012	0.000551	CbGpPWpGaD
Clodronate—SLC25A5—Disease—GSK3B—Alzheimer's disease	0.000118	0.000543	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PLCB1—Alzheimer's disease	0.000118	0.000539	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CREB1—Alzheimer's disease	0.000117	0.000539	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	0.000117	0.000537	CbGpPWpGaD
Clodronate—SLC25A5—Disease—INS—Alzheimer's disease	0.000117	0.000536	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000115	0.000528	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CALM1—Alzheimer's disease	0.000115	0.000527	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CALM1—Alzheimer's disease	0.000115	0.000527	CbGpPWpGaD
Clodronate—SLC25A6—Disease—APOE—Alzheimer's disease	0.000115	0.000525	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—APOE—Alzheimer's disease	0.000115	0.000525	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—LPL—Alzheimer's disease	0.000115	0.000525	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ABCA1—Alzheimer's disease	0.000114	0.000522	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CAV1—Alzheimer's disease	0.000114	0.00052	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—CAV1—Alzheimer's disease	0.000113	0.00052	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.000111	0.000508	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	0.000109	0.0005	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	0.000108	0.000493	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—Alzheimer's disease	0.000107	0.00049	CbGpPWpGaD
Clodronate—SLC25A4—Disease—LPL—Alzheimer's disease	0.000107	0.000489	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOTCH1—Alzheimer's disease	0.000106	0.000485	CbGpPWpGaD
Clodronate—PTGS2—Disease—ITM2B—Alzheimer's disease	0.000105	0.00048	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PRKCG—Alzheimer's disease	0.000104	0.000476	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—MTHFR—Alzheimer's disease	0.000103	0.000473	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS3—Alzheimer's disease	0.000102	0.00047	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000101	0.000465	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPARG—Alzheimer's disease	9.98e-05	0.000457	CbGpPWpGaD
Clodronate—SLC25A6—Disease—GSK3B—Alzheimer's disease	9.93e-05	0.000455	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CREB1—Alzheimer's disease	9.85e-05	0.000451	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	9.84e-05	0.000451	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CCR5—Alzheimer's disease	9.84e-05	0.000451	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARGC1A—Alzheimer's disease	9.82e-05	0.00045	CbGpPWpGaD
Clodronate—SLC25A6—Disease—INS—Alzheimer's disease	9.79e-05	0.000449	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—INS—Alzheimer's disease	9.79e-05	0.000448	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—HMOX1—Alzheimer's disease	9.77e-05	0.000448	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CALM1—Alzheimer's disease	9.63e-05	0.000441	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—Alzheimer's disease	9.61e-05	0.00044	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—Alzheimer's disease	9.6e-05	0.00044	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CAV1—Alzheimer's disease	9.51e-05	0.000436	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	9.44e-05	0.000433	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	9.44e-05	0.000432	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—Alzheimer's disease	9.37e-05	0.00043	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CALM1—Alzheimer's disease	8.98e-05	0.000412	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—Alzheimer's disease	8.95e-05	0.00041	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—LPL—Alzheimer's disease	8.94e-05	0.00041	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CAV1—Alzheimer's disease	8.87e-05	0.000406	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DHCR24—Alzheimer's disease	8.78e-05	0.000402	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—Alzheimer's disease	8.59e-05	0.000394	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—Alzheimer's disease	8.58e-05	0.000393	CbGpPWpGaD
Clodronate—PTGS2—Disease—GAPDHS—Alzheimer's disease	8.38e-05	0.000384	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—Alzheimer's disease	8.36e-05	0.000383	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—Alzheimer's disease	8.34e-05	0.000382	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOTCH1—Alzheimer's disease	8.26e-05	0.000378	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—INS—Alzheimer's disease	8.2e-05	0.000376	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.19e-05	0.000375	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—Alzheimer's disease	8.05e-05	0.000369	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—Alzheimer's disease	7.85e-05	0.00036	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—Alzheimer's disease	7.85e-05	0.00036	CbGpPWpGaD
Clodronate—SLC25A4—Disease—GSK3B—Alzheimer's disease	7.75e-05	0.000355	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CREB1—Alzheimer's disease	7.69e-05	0.000352	CbGpPWpGaD
Clodronate—SLC25A4—Disease—INS—Alzheimer's disease	7.64e-05	0.00035	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	7.61e-05	0.000349	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CALM1—Alzheimer's disease	7.52e-05	0.000345	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—Alzheimer's disease	7.49e-05	0.000343	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	7.47e-05	0.000342	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CA4—Alzheimer's disease	7.47e-05	0.000342	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	7.45e-05	0.000341	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CAV1—Alzheimer's disease	7.42e-05	0.00034	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.3e-05	0.000334	CbGpPWpGaD
Clodronate—PTGS2—Disease—TTR—Alzheimer's disease	7.27e-05	0.000333	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—Alzheimer's disease	7.19e-05	0.00033	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	7.02e-05	0.000322	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	6.85e-05	0.000314	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	6.84e-05	0.000314	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—Alzheimer's disease	6.78e-05	0.000311	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—Alzheimer's disease	6.7e-05	0.000307	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	6.65e-05	0.000305	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	6.58e-05	0.000302	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—Alzheimer's disease	6.58e-05	0.000301	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—Alzheimer's disease	6.53e-05	0.000299	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INS—Alzheimer's disease	6.4e-05	0.000293	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLD3—Alzheimer's disease	6.35e-05	0.000291	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.35e-05	0.000291	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.27e-05	0.000288	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—Alzheimer's disease	6.13e-05	0.000281	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	6.09e-05	0.000279	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.95e-05	0.000273	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	5.86e-05	0.000268	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	5.8e-05	0.000266	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	5.75e-05	0.000263	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—Alzheimer's disease	5.68e-05	0.00026	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ND1—Alzheimer's disease	5.66e-05	0.000259	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—Alzheimer's disease	5.61e-05	0.000257	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.53e-05	0.000253	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	5.53e-05	0.000253	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	5.42e-05	0.000248	CbGpPWpGaD
Clodronate—PTGS2—Disease—SNCA—Alzheimer's disease	5.4e-05	0.000248	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—Alzheimer's disease	5.13e-05	0.000235	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—Alzheimer's disease	5.11e-05	0.000234	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	5.07e-05	0.000232	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.06e-05	0.000232	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSENEN—Alzheimer's disease	4.81e-05	0.000221	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	4.78e-05	0.000219	CbGpPWpGaD
Clodronate—PTGS2—Disease—APH1A—Alzheimer's disease	4.75e-05	0.000218	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—Alzheimer's disease	4.71e-05	0.000216	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.66e-05	0.000213	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCSTN—Alzheimer's disease	4.62e-05	0.000212	CbGpPWpGaD
Clodronate—PTGS2—Disease—LRP1—Alzheimer's disease	4.51e-05	0.000207	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—Alzheimer's disease	4.43e-05	0.000203	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	4.37e-05	0.0002	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.36e-05	0.0002	CbGpPWpGaD
Clodronate—PTGS2—Disease—TPI1—Alzheimer's disease	4.35e-05	0.0002	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.3e-05	0.000197	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—Alzheimer's disease	4.28e-05	0.000196	CbGpPWpGaD
Clodronate—PTGS2—Disease—EIF2AK2—Alzheimer's disease	4.09e-05	0.000188	CbGpPWpGaD
Clodronate—PTGS2—Disease—GAPDH—Alzheimer's disease	4.02e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.97e-05	0.000182	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—Alzheimer's disease	3.95e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.95e-05	0.000181	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—Alzheimer's disease	3.94e-05	0.000181	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSEN2—Alzheimer's disease	3.76e-05	0.000172	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.69e-05	0.000169	CbGpPWpGaD
Clodronate—PTGS2—Disease—CST3—Alzheimer's disease	3.67e-05	0.000168	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TPI1—Alzheimer's disease	3.65e-05	0.000167	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CHAT—Alzheimer's disease	3.65e-05	0.000167	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MAOB—Alzheimer's disease	3.5e-05	0.00016	CbGpPWpGaD
Clodronate—PTGS2—Disease—IAPP—Alzheimer's disease	3.44e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GAPDH—Alzheimer's disease	3.36e-05	0.000154	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—Alzheimer's disease	3.34e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.33e-05	0.000152	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—Alzheimer's disease	3.31e-05	0.000152	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.3e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—A2M—Alzheimer's disease	3.25e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.25e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO1—Alzheimer's disease	3.16e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP3CA—Alzheimer's disease	3.15e-05	0.000144	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—Alzheimer's disease	3.08e-05	0.000141	CbGpPWpGaD
Clodronate—PTGS2—Disease—GAB2—Alzheimer's disease	3.02e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Disease—GSK3A—Alzheimer's disease	2.99e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Disease—APP—Alzheimer's disease	2.94e-05	0.000135	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.9e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACHE—Alzheimer's disease	2.83e-05	0.00013	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INPP5D—Alzheimer's disease	2.79e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.74e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTGS1—Alzheimer's disease	2.65e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO1—Alzheimer's disease	2.65e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	2.6e-05	0.000119	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—Alzheimer's disease	2.58e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADAM10—Alzheimer's disease	2.53e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BCHE—Alzheimer's disease	2.46e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLCB1—Alzheimer's disease	2.32e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCA1—Alzheimer's disease	2.25e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Disease—LPL—Alzheimer's disease	2.11e-05	9.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKCG—Alzheimer's disease	2.05e-05	9.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CCR5—Alzheimer's disease	1.94e-05	8.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.94e-05	8.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.93e-05	8.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—Alzheimer's disease	1.9e-05	8.71e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALM1—Alzheimer's disease	1.78e-05	8.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—Alzheimer's disease	1.77e-05	8.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPL—Alzheimer's disease	1.77e-05	8.1e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CAV1—Alzheimer's disease	1.75e-05	8.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—Alzheimer's disease	1.65e-05	7.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOTCH1—Alzheimer's disease	1.63e-05	7.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.59e-05	7.29e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GSK3B—Alzheimer's disease	1.53e-05	7.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CREB1—Alzheimer's disease	1.52e-05	6.96e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—INS—Alzheimer's disease	1.51e-05	6.93e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CALM1—Alzheimer's disease	1.49e-05	6.81e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—Alzheimer's disease	1.48e-05	6.79e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAV1—Alzheimer's disease	1.47e-05	6.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—Alzheimer's disease	1.33e-05	6.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—Alzheimer's disease	1.29e-05	5.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INS—Alzheimer's disease	1.27e-05	5.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—Alzheimer's disease	1.11e-05	5.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—Alzheimer's disease	8.76e-06	4.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—Alzheimer's disease	6.6e-06	3.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—Alzheimer's disease	6.09e-06	2.79e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—Alzheimer's disease	5.1e-06	2.34e-05	CbGpPWpGaD
